Only one NCO patient (ID 303) in our study had TP53 −/− clones and subsequent complex SVs; however, this patient had high-grade dysplasia at the initial timepoint and died of other causes 2.81 years after T2, and likely represents a censored case that would have progressed to cancer given additional follow-up time. The gene discussed is TP53; the disease is cancer.